3,651
Views
176
CrossRef citations to date
0
Altmetric
Articles

‘I am not a man’: Trans-specific barriers and facilitators to PrEP acceptability among transgender women

, , &
Pages 1060-1075 | Received 28 Feb 2015, Accepted 27 Jan 2016, Published online: 10 Mar 2016

References

  • Baral, S. D., Poteat, T., Stromdahl, S., Wirtz, A. L., Guadamuz, T. E., & Beyrer, C. (2013). Worldwide burden of HIV in transgender women: A systematic review and meta-analysis. Lancet Infectious Diseases, 13(3), 214–222. doi:10.1016/S1473-3099(12)70315-8S1473-3099(12)70315-8[pii]
  • Bauer, G., Hammond, R., Travers, R., Kaay, M., Hohenadel, K., & Boyce, M. (2009). “I don't think this is theoretical; this is our lives”: How erasure impacts health care for transgender people. Journal of the Association of Nurses in AIDS Care, 20(5), 348–361. doi:10.1016/j.jana.2009.07.004
  • Boellstorff, T. (2011). But do not identify as gay: A proleptic genealogy of the MSM category. Cultural Anthropology, 26, 287–312. doi:10.1111/j.1548-1360.2011.01100.x
  • Centers for Disease Control and Prevention. (2008). HIV incidence. Morbidity and mortality weekly report. Retrieved from http://www.cdc.gov/hiv/topics/surveillance/incidence.htm
  • Centers for Disease Control and Prevention. (2011). Interim guidance: Pre-exposure prophylaxis for the prevention of HIV infection in men who have sex with men. Morbidity and Mortality Weekly Report, 60(3), 65–68.
  • Coe, A. B., Moczygemba, L. R., Gatewood, S. B. S., Osborn, R. D., Matzke, G. R., & Goode, J.-V. R. (2012). Medication adherence challenges among patients experiencing homelessness in a behavioral health clinic. Research in Social and Administrative Pharmacy. Retrieved from http://dx.doi.org/10.1016/j.sapharm.2012.11.004
  • Colton Meier, S. L., Fitzgerald, K. M., Pardo, S. T., & Babcock, J. (2011). The effects of hormonal gender affirmation treatment on mental health in female-to-male transsexuals. Journal of Gay & Lesbian Mental Health, 15(3), 281–299. doi:10.1080/19359705.2011.581195
  • Deutsch, M., Glidden, D., Sevelius, J., Keatley, J., McMahan, V., Guanira, J., … Grant, R. M. (2015). Preexposure chemoprophylaxis for HIV prevention in transgender women: A subgroup analysis of the iPrEx trial. The Lancet HIV, 2(12), e512–e519. doi:10.1016/S2352-3018(15)00206-4
  • Escudero, D. J., Kerr, T., Operario, D., Socías, M. E., Sued, O., & Marshall, B. D. L. (2014). Inclusion of trans women in pre-exposure prophylaxis trials: A review. AIDS Care, 27(5), 637–641. doi:10.1080/09540121.2014.986051
  • Fiereck, K. (2013). Cultural conundrums: The ethics of epidemiology and the problems of population in implementing pre-exposure prophylaxis. Developing World Bioethics ( 1471–8847. (Electronic)). doi:10.1111/dewb.12034
  • Golub, S. A., Gamarel, K. E., Rendina, H. J., Surace, A., & Lelutiu-Weinberger, C. L. (2013). From efficacy to effectiveness: Facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care STDS, 27(4), 248–254. doi:10.1089/apc.2012.0419
  • Grant, J., Mottet, L., Tanis, J., Harrison, J., Herman, J., & Keisling, M. (2011). Injustice at every turn: A report of the national transgender discrimination survey. Washington. Retrieved from http://www.thetaskforce.org/static_html/downloads/reports/reports/ntds_full.pdf
  • Grant, R., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., … Glidden, D. V. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine, 363(27), 2587–2599. doi:10.1056/NEJMoa1011205
  • Herbst, J., Jacobs, E., Finlayson, T., McKleroy, V., Neumann, M., & Crepaz, N. (2008). Estimating HIV prevalence and risk behaviors of transgender persons in the United States: A systematic review. AIDS and Behavior, 12(1), 1–17. doi:10.1007/s10461-007-9299-3
  • Liu, A., Cohen, S., Follansbee, S., Cohan, D., Weber, S., Sachdev, D., & Buchbinder, S. (2014). Early experiences implementing pre-exposure rrophylaxis (PrEP) for HIV prevention in San Francisco. PLoS Medicine, 11(3), e1001613. doi:10.1371/journal.pmed.1001613
  • Machtinger, E., Haberer, J., Wilson, T., & Weiss, D. (2012). Recent trauma is associated with antiretroviral failure and HIV transmission risk behavior among HIV-positive women and female-identified transgenders. AIDS and Behavior, 16(8), 2160–2170. doi:10.1007/s10461-012-0158-5
  • Marcus, J. L., Buisker, T., Horvath, T., Amico, K. R., Fuchs, J. D., Buchbinder, S. P., … Liu, A. Y. (2014). Helping our patients take HIV pre-exposure prophylaxis (PrEP): A systematic review of adherence interventions. HIV Medicine, 15(7), 385–395. doi:10.1111/hiv.12132
  • Mascolini, M. (2011). TDF/FTC PrEP durable in MSM, but MSM and transgender responses differ. Paper presented at the 6th IAS conference on HIV pathogenesis, treatment and prevention, Rome, Italy.
  • Nadal, K., Davidoff, K., & Fujii-Doe, W. (2014). Transgender women and the sex work industry: Roots in systemic, institutional, and interpersonal discrimination. Journal of Trauma & Dissociation, 15(2), 169–183. doi:10.1080/15299732.2014.867572
  • Nuttbrock, L., Bockting, W., Hwahng, S., Rosenblum, A., Mason, M., Macri, M., & Becker, J. (2009). Gender identity affirmation among male-to-female transgender persons: A life course analysis across types of relationships and cultural/lifestyle factors. Sexual and Relationship Therapy, 24(2), 108–125. doi:110.1080/14681990902926764
  • Nuttbrock, L., Rosenblum, A., & Blumenstein, R. (2002). Transgender identity affirmation and mental health. International Journal of Transgenderism, 6(4).Retrieved from http://www.iiav.nl/ezines/web/ijt/97-03/numbers/symposion/ijtvo06no04_03.htm
  • Operario, D., Soma, T., & Underhill, K. (2008). Sex work and HIV status among transgender women: Systematic review and meta-analysis. Journal of Acquired Immune Deficiency Syndromes, 48(1), 97–103. doi:10.1097/QAI.0b013e31816e3971
  • Poteat, T., Wirtz, A. L., Radix, A., Borquez, A., Silva-Santisteban, A., Deutsch, M. B., … Operario, D. (2014). HIV risk and preventive interventions in transgender women sex workers. Lancet. doi:10.1016/S0140-6736(14)60833-3
  • San Francisco Department of Public Health. (2014). HIV/AIDS annual epidemiology report. San Francisco. Retrieved from https://www.sfdph.org/dph/files/reports/RptsHIVAIDS/HIV-EpidemiologyAnnualReport-2014.pdf
  • Santos, G.-M., Wilson, E. C., Rapues, J., Macias, O., Packer, T., & Raymond, H. F. (2014). HIV treatment cascade among transgender women in a San Francisco respondent driven sampling study. Sexually Transmitted Infections. doi:10.1136/sextrans-2013-051342
  • Sevelius, J. (2013). Gender affirmation: A framework for conceptualizing risk behavior among transgender women of color. Sex Roles, 68(11–12), 675–689. doi:10.1007/s11199-012-0216-5
  • Sevelius, J., Carrico, A., & Johnson, M. (2010). Antiretroviral therapy adherence among transgender women living with HIV. Journal of the Association of Nurses in AIDS Care, 21(3), 256–264. doi:10.1016/j.jana.2010.01.005 
  • Sevelius, J., Keatley, J., & Gutierrez-Mock, L. (2011). HIV/AIDS programming in the United States: Considerations affecting transgender women and girls. Women's Health Issues, 21(6, Suppl), S278–S282. doi:10.1016/j.whi.2011.08.001
  • Sevelius, J., Patouhas, E., Keatley, J., & Johnson, M. (2014). Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus. Annals of Behavioral Medicine, 47(1), 5–16. doi:10.1007/s12160-013-9565-8
  • Sevelius, J., Saberi, P., & Johnson, M. (2014). Correlates of antiretroviral adherence and viral load among transgender women living with HIV. AIDS Care, 1–7. doi:10.1080/09540121.2014.896451
  • Walker, L. O., & Avant, K. C. (2005). Strategies for theory construction in nursing (4th ed.). Upper Saddle River, NJ: Pearson/Prentice Hall.
  • Whiteman, M. K., Jeng, G., Samarina, A., Akatova, N., Martirosyan, M., Kissin, D. M., … Jamieson, D. J. (2015). Associations of hormonal contraceptive use with measures of HIV disease progression and antiretroviral therapy effectiveness. Contraception. http://dx.doi.org/10.1016/j.contraception.2015.07.003
  • Wilson, E. C., Jin, H., Liu, A., & Raymond, H. F. (2015). Knowledge, indications and willingness to take pre-exposure prophylaxis among transwomen in San Francisco, 2013. PLoS ONE, 10(6), e0128971. doi:10.1371/journal.pone.0128971
  • World Health Organization. (2012). Guidance on Pre-Exposure Oral Prophylaxis (PrEP) for serodiscordant couples, men and transgender women who have sex with men at high risk of HIV: Recommendations for use in the context of demonstration projects. Retrieved from http://www.who.int/hiv/pub/guidance_prep/en/
  • Yang, D., Chariyalertsak, C., Wongthanee, A., Kawichai, S., Yotruean, K., Saokhieo, P., … Chariyalertsak, S. (2013). Acceptability of pre-exposure prophylaxis among men who have sex with men and transgender women in Northern Thailand. PLoS ONE, 8(10). doi:10.1371/journal.pone.0076650
  • Young, R. M., & Meyer, I. H. (2005). The trouble With “MSM” and “WSW”: Erasure of the sexual-minority person in public health discourse. American Journal of Public Health, 95(7), 1144–1149. doi:10.2105/AJPH.2004.046714

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.